Evidence map›Paper›PMID 33658653›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.

Nora Penzel, Linda A Antonucci, Linda T Betz, Rachele Sanfelici, Johanna Weiske, Oliver Pogarell, Paul Cumming, Boris B Quednow, Oliver Howes, Peter Falkai and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Consequences of adolescent drug use.Translational psychiatry · 2023
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 19 institutions in 6 countries.

Nora PenzelDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Linda A AntonucciDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Linda T BetzDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0003-1741-4069
Rachele SanfeliciDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Johanna WeiskeDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Oliver PogarellDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Paul CummingInstitute of Nuclear Medicine, Inselspital, Bern University, Bern, Switzerland.
Boris B QuednowExperimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital of the University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7933-2865
Oliver HowesDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Peter FalkaiDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Rachel UpthegroveInstitute of Mental Health, University of Birmingham, Birmingham, UK.
Alessandro BertolinoDepartment of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy.
Stefan BorgwardtDepartment of Psychiatry (UPK), University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-5792-3987
Paolo BrambillaDepartment of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-4021-8456
Rebekka LencerDepartment of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.ORCID http://orcid.org/0000-0003-4032-7297
Eva MeisenzahlDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Marlene RosenDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Theresa HaidlDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Lana Kambeitz-IlankovicDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Stephan RuhrmannDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-6022-2364
Raimo R K SalokangasDepartment of Psychiatry, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0002-8532-1596
Christos PantelisMelbourne Neuropsychiatry Centre, Melbourne Health, University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-9565-0238
Stephen J WoodInstitute of Mental Health, University of Birmingham, Birmingham, UK.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Joseph KambeitzDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. joseph.kambeitz@uk-koeln.de.ORCID http://orcid.org/0000-0002-8988-3959
PRONIA Consortium
Ludwig-Maximilians-Universität München · DEUniversity of Cologne · DEUniversity of Turku · FIUniversity of Bari Aldo Moro · ITUniversity of Basel · CHUniversity of Milan · ITUniversity of Birmingham · GBHeinrich Heine University Düsseldorf · DEUniversity of Münster · DEUniversity of Udine · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITKing's College London · GBThe University of Melbourne · AUInstitute of Mental Health · GBIRCCS Eugenio Medea · ITMax Planck Institute for Human Cognitive and Brain Sciences · DEOspedale San Paolo · ITQueensland University of Technology · AUUniversity of Zurich · CH

Funding

Medical Research Council MC_U120097115Medical Research Council MR/N027078/1
6 · The paper itself

Abstract

Cannabis use during adolescence is associated with an increased risk of developing psychosis. According to a current hypothesis, this results from detrimental effects of early cannabis use on brain maturation during this vulnerable period. However, studies investigating the interaction between early cannabis use and brain structural alterations hitherto reported inconclusive findings. We investigated effects of age of cannabis initiation on psychosis using data from the multicentric Personalized Prognostic Tools for Early Psychosis Management (PRONIA) and the Cannabis Induced Psychosis (CIP) studies, yielding a total sample of 102 clinically-relevant cannabis users with recent onset psychosis. GM covariance underlies shared maturational processes. Therefore, we performed source-based morphometry analysis with spatial constraints on structural brain networks showing significant alterations in schizophrenia in a previous multisite study, thus testing associations of these networks with the age of cannabis initiation and with confounding factors. Earlier cannabis initiation was associated with more severe positive symptoms in our cohort. Greater gray matter volume (GMV) in the previously identified cerebellar schizophrenia-related network had a significant association with early cannabis use, independent of several possibly confounding factors. Moreover, GMV in the cerebellar network was associated with lower volume in another network previously associated with schizophrenia, comprising the insula, superior temporal, and inferior frontal gyrus. These findings are in line with previous investigations in healthy cannabis users, and suggest that early initiation of cannabis perturbs the developmental trajectory of certain structural brain networks in a manner imparting risk for psychosis later in life.

Indexed as

CannabisPsychotic DisordersSchizophreniaAdolescentGray MatterHumansMagnetic Resonance Imaging

Identifiers

PMID33658653
PMCPMC8209059
OpenAlexW3134251476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.